Progression of human immunodeficiency virus infection in patients with tuberculosis disease: A cohort study in Bordeaux, France, 1988-1994

American Journal of Epidemiology

Volumn 145, Issue 4, 1997, Pages 293-300

  Leroy, Valériane ^a,g   Rachid Salmi, L ^a   Dupon, Michel ^b   Sentilhes, Angélique ^b   Texier Maugein, Jeannette ^b   Dequae, Laurence ^a   Dabis, Francois ^a   Salamon, Roger ^a   Dabis, F ^b   Salamon, R ^b   Chene G ^b   Constans, J ^b,c   Dupon, M ^b,c   Lacoste, D ^b,c   Morlat, P ^b,c   Moreau, J F ^b   Pellegrin, J L ^b,c   Ragnaud, J M ^b,c   Aubertin, J ^c   Buisson, M ^c   Sire, S ^c   Beylot, J ^c   Bernard, N ^c   Beylot, C ^c   Doutre, M S ^c   Conri, C ^c   Couzigou, P ^c   Geniaux, M ^c   Simon, A ^c   Lacut, J Y ^c   Paty, M C ^c   Leng, B ^c   Desforges Lasseur, C ^c   Rispal, P ^c   Le Bras, M ^c   Monlun, E ^c   Pivetaud, J P ^c   Moreau, F ^c   Mestre, C ^c   Paccalin, J ^c   Dabadie, H ^c   Series, C ^c   Taytard, A ^c   Vernejoux, J M ^c   Loste, P ^d   Blanchard, I ^d   Ferrand, M ^e   Bonnal, F ^e   Blanchard, Y ^e   Farbos, S ^e   Carde, N ^f   Ceccaldi, J ^f   Jacquelin, X ^f   Brossard, G ^g   Caie, J ^g   Decoin, M ^g   Dequae, L ^g   Errecart Barbotin, M ^g   Touchard, D ^g   Belougne, D ^g   Commenges, D ^g   Hubert, J B ^g   Marimoutou, C ^g   more..

^a UNIVERSITÉ DE BORDEAUX   (France)

^b BORDEAUX UNIVERSITY HOSPITAL   (France)

^c University de Bordeaux   (France)

^d Department of Infectious Diseases Dax Hospital   (France)

^e Bayonne Medical Center   (United States)

^f Libourne Hospital   (France)

^g Villeneuve sur Lot Hospital   (Italy)

Author keywords

HIV infections; natural history; tuberculosis

Indexed keywords

ARTICLE; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MYCOBACTERIUM TUBERCULOSIS; OPPORTUNISTIC INFECTION; PROPHYLAXIS; RISK ASSESSMENT; TUBERCULOSIS;

EID: 1842295742     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a009105     Document Type: Article

References (39)

1. Dolin PJ, Raviglione MC, Kochi A. Global tuberculosis incidence and mortality during 1990-2000. Bull World Health Organ 1994;72:213-20.
2. Raviglione MC, Snider DE, Kochi A. Global epidemiology of tuberculosis - morbidity and mortality of a worldwide epidemic. JAMA 1995;273:220-6.
3. Selwyn PA, Hartel D, Lewis VA, et al. A prospective study of the risk of tuberculosis among intravenous drug users with immunodeficiency virus infection. N Engl J Med 1989;320: 545-50.
4. De Cock KM, Gnaore E, Adjorlolo G, et al. Risk of tuberculosis in patients with HIV-I and HIV-II infections in Abidjan, Ivory Coast. BMJ 1991;302:496-9.
5. Di Perri G, Micciolo R, Vento S, et al. Risk of reactivation of tuberculosis in the course of human immunodeficiency virus infection. Eur J Med 1993;2:264-8.
6. Centers for Disease Control. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992;41:1-19.
7. Chaisson RE, Schecter GF, Theuer CP, et al. Tuberculosis in patients with the acquired immunodeficiency syndrome: clinical features, responses to therapy, and survival. Am Rev Respir Dis 1987;136:570-4.
8. Braun MM, Badi N, Ryder RW. A retrospective cohort study of the risk of tuberculosis among women of childbearing age with HIV infection in Zaire. Am Rev Respir Dis 1991;143: 501-4.
9. Lucas SB, Hounnou A, Peacock C, The mortality and pathology of HIV infection in a West African city. AIDS 1993;7:1569-79.
10. Leroy, V, Msellati P, Lepage P, Four years of natural history of HIV-1 infection in African women of reproductive age: a prospective cohort study in Kigali, Rwanda, 1988-1993. J Acquir Immune Defic Syndr Hum Retrovirol 1995;9:415-21.
11. De Cock KM, Grant A, Porter JDH. Preventive therapy for tuberculosis in HIV-infected persons: international recommendations, research, and practice. Lancet 1995;345:833-6.
12. Shafer R, Edlin B. Tuberculosis in patients infected with human immmunodeficiency virus: perspective on the past decade. Clin Infect Dis 1996;22:683-704.
13. Small PM, Scheeler GF, Goodman PC, et al. Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. N Engl J Med 1991;324:289-94.
14. Pape JW, Jean SS, Ho JL, et al. Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Lancet 1993;342:268-72.
15. Perneger TV, Sudre P, Lundgren JD, et al. Does the onset of tuberculosis in AIDS predict shorter survival? Results of a cohort study in 17 European countries over 13 years. BMJ 1995;311:1468-71.
16. Wallis RS, Vjecha M, Amir-Tahmasseb M, et al. Influence of tuberculosis on HIV-1: enhanced cytokine expression and elevated b2 microglobulin in HIV-1 associated tuberculosis. J Infect Dis 1993;167:43-8.
17. Zhang M, Gong J, Vlyer D, et al. T cell cytokine responses in persons wilh tuberculosis and HIV-infection. J Clin Invest 1994;94:2435-42.
18. Grange JM, Stanford JL, Rook GAW. Tuberculosis and cancer: parallels in host responses and therapeutic approaches? Lancet 1995;345:1350-2.
19. Whalen C, Horsburgh CR, Horn D, et al. Accelerated course of human immunodeficiency virus after tuberculosis. Am J Respir Crit Care Med 1995;151:129-35.
20. Castro KG. Tuberculosis as an opportunistic disease in persons infected with human immunodeficiency virus. Clin Infect Dis 1995;21(suppl 1):S66-71.
21. American Thoracic Society and Centers for Disease Control and Prevention. Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Dis Crit Care Med 1994;149:1359-74.
22. Anglaret X, Taelman H, Ladner J, et al. Tuberculosis and chemoprophylaxis in Africa. Lancet 1995;345:867-8.
23. Perriens JH, SaintLouis ME, Mukadi YB, et al. Pulmonary tuberculosis in HIV-infected patients in Zaire - a controlled trial of treatment for either 6 or 12 months. N Engl J Med 1995;332:779-84.
24. Dabis F, Chêne G, Salamon R, et al. Hospital-based surveillance of HIV infection: Bordeaux, France, 1983-1990. AIDS 1991;5:774-5.
25. Chêne G, Dabis F, Salamon R, et al. Hospital-based surveillance of HIV infection: epidemiological trends in Bordeaux, France, 1983-1989. Eur J Epidemiol 1992;8:58-66.
26. Institut National de la Statistique et des Etudes Economiques. Recensement général de la population. (In French). Paris: INSEE, 1991:256.
27. Direction Générale de la Santé. Surveillance du Sida en France. (In French). Bull Epidemiol Hebdomadaire 1995;8:31-7.
28. Centers for Disease Control. Case definition for public health surveillance: recommendations and report. MMWR Morb Mortal Wkly Rep 1990;39:39-40.
29. Centers for Disease Control. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. MMWR Morb Mortal Wkly Rep 1986;35:334-9.
30. Rothman KJ. Modern epidemiology. Boston: Little, Brown, 1986.
31. Chen R, Wei L, Huang H. Methods for calculation of follow-up rate in a cohort study. (Letter). Int J Epidemiol 1993;22:950-2.
32. Kaplan EL, Meier P. Nonparametric estimation from incomplete samples. J Am Stat Assoc 1958;53:457-81.
33. Cox DR, Oakes D. Analysis of survival data. London: Chapman & Hall, 1984.
34. Taylor JMG, Fahey JL, Detels R, et al. CD4 percentage, CD4 number and CD4:CD8 ratio in HIV infection: which to use and how to use. J Acquir Immune Defic Syndr Hum Retrovirol 1989;2:114-24.
35. Dupon M, Texier-Maugein J, Leroy V, et al. Tuberculosis and HIV infection: a cohort study of incidence and susceptibility to antituberculous drugs, Bordeaux, 1985-1993. AIDS 1995;9:577-83.
36. Dupon M, Ragnaud JM, Groupe des Infectiolologues du Sud de la France. Tuberculosis in patients infected with human immunodeficiency virus: a retrospective multicentre study of 123 cases in France. Q J Med 1992;306:719-30.
37. Ackah AN, Coulibaly D, Digbeu H, et al. Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Côte d'Ivoire. Lancet 1995;345:607-10.
38. Martin DJ, Sim JGM, Sole GJ, et al. CD4+ lymphocyte count in African patients co-infected with HIV and tuberculosis. J Acquir Immune Defic Syndr Hum Retrovirol 1995;8:386-91.
39. Mellors J, Kingsley LA, Rinaldo CR, et al. Quantification of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995;122:573-9.